Stock listing

NASDAQ:MYOK MyoKardia Inc Stock

Follow MyoKardia Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MYOK

$224.91 USD

Close on Nov 18, 2020 · No longer trades

Oct 28, 2015 to last close +2,149% · weekly closes, Oct 28, 2015 – Nov 18, 2020
Lowest – highest close
$6.73 – $224.91 USDSince Oct 28, 2015 · lowest Feb 16, 2016 · highest Nov 16, 2020

Delisted NASDAQ:MYOK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MYOK
Asset type
Stock
Exchange
NASDAQ
Currency
USD

MyoKardia Inc on 6ix

Decks
4 decks · latest May 11, 2020

Decks

DeckKindSlidesDate
Corporate Update (May 2020)Corporate update20 slidesMay 11, 2020
Investor Presentation (March 2017)Investor deck39 slidesMar 6, 2017
Technical Presentation (July 2016)Technical10 slidesJul 11, 2016
Investor Presentation (March 2016)Investor deck28 slidesMar 8, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kimberly Popovits
Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Rhythm Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2026); EXACT Sciences Corporation (Director · Since at least Jan 2, 2025); 10x Genomics, Inc. (Director · Since at least Mar 26, 2020); Kiniksa Pharmaceuticals International, plc (Director · Since at least May 23, 2018); Talis Biomedical Corp (Director · Feb 11, 2021 – Jun 9, 2023 · Past); Genomic Health Inc (President and CEO, Director · Nov 3, 2016 – Nov 8, 2019 · Past)
Director · Mar 15, 2017 – Nov 17, 2020 · Past
David Meeker
Other companies: Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Pharvaris N.V. (Chair of the Board · Since at least Mar 18, 2026); Trevi Therapeutics, Inc. (Chairman · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Chairman, President, and Chief Executive Officer · Since at least Oct 4, 2017); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Savient Pharmaceuticals Inc (Director · Jan 7, 2013 – Jan 7, 2013 · Past)
Director · Apr 17, 2017 – Nov 17, 2020 · Past
Kevin P Starr
Other companies: Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Aug 17, 2015 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Jun 15, 2023 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – Sep 24, 2015 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past); Human Genome Sciences Inc (Director · May 3, 2007 – Jul 10, 2007 · Past)
Director · Oct 28, 2015 – Mar 7, 2018 · Past
Sunil Agarwal
Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2024); Arvinas, Inc. (Director · Since at least Jun 15, 2023); Sana Biotechnology, Inc. (EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past); Juno Therapeutics Inc (President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past)
Director · Mar 4, 2016 – Nov 17, 2020 · Past
William C. Fairey
Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Since at least Apr 18, 2024); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); ChemoCentryx Inc. (Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past)
EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past
Mary B. Cranston
Other companies: TPG Inc. (Director · Since at least Jan 13, 2022); Chemours Company (the) (Director · Since at least Apr 29, 2021); Visa Inc. (Director · Dec 11, 2020 – Jan 24, 2023 · Past); McAfee Inc (Director · Oct 22, 2020 – Mar 1, 2022 · Past)
Director · Jun 29, 2020 – Nov 17, 2020 · Past
Bob McDowell
Other companies: Kardigan, Inc. (Co-Founder and Scientific Adviser · Since at least Nov 5, 2026); Sunesis Pharmaceuticals Inc (Vice President, Research · Sep 11, 2007 – Sep 13, 2007 · Past)
Chief Scientific Officer · Oct 28, 2015 – Nov 17, 2020 · Past
Jonathan C. Fox
Other companies: Edgewise Therapeutics, Inc. (Director · Since at least Mar 2, 2023); Eidos Therapeutics Inc (See Remarks · Jun 19, 2018 – Jan 26, 2021 · Past)
Chief Medical Officer · Oct 28, 2015 – Apr 29, 2016 · Past
Marc Semigran
Other companies: Edgewise Therapeutics, Inc. (Chief Development Officer · Dec 19, 2022 – Dec 24, 2024 · Past); ProKidney Corp. (Director · Jun 29, 2021 – Jun 29, 2021 · Past)
Chief Medical Officer · Dec 1, 2016 – Feb 8, 2019 · Past
Mark L Perry
Other companies: Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Oct 5, 2022 · Past); NVIDIA Corporation (Director · May 20, 2010 – Jun 26, 2024 · Past)
Director · Oct 28, 2015 – Nov 17, 2020 · Past
All 13 people
PersonSeat
Anastasios Gianakakos
Other companies: Kardigan, Inc. (President & CEO, Director · Since at least Jun 17, 2026)
President and CEO, Director · Oct 28, 2015 – Nov 17, 2020 · Past
Denelle J Waynick
Other companies: Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past)
Chief Legal Officer · Jun 29, 2020 – Nov 17, 2020 · Past
Joseph LambingSee Remarks · Oct 28, 2015 – Feb 8, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about MyoKardia Inc.